As this patient collection consisted of low stage HGS carcinomas, this finding lends further support to prior studies of early/low stage HGS, which showed somatic TP53 mutations in serous tubal intraepithelial carcinomas from women with germline mutations in BRCA1 or BRCA2 (38). Here, TP53 is linked to carcinoma.